BRATICA JOSEPH (Principal Financial Officer) sold 12.1% of their position (1.13K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $180.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/10/2020ACC: 0001209191-20-062807
Officer· Principal Financial Officer
Since Aug 2020
-1.13K
Net shares
Net seller
$180.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.13K acquired · 2.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.13K
Price / share
$29.60
Trade value
$33.30K
% of position
13.8%
12/8/2020
8.14K→9.27K
Common Stock
Direct
Shares
−1.13K
Price / share
$160.00
Trade value
$180K
% of position
12.1%
12/8/2020
9.27K→8.14K
Total
Net shares
+0.00
Net value
-$146.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2020 | M · Option Exercise | +1.13K | $29.60 | $33.30K | 13.8% | 8.14K | 9.27K |
| Common Stock Direct | 12/8/2020 | S · Sale | −1.13K | $160.00 | $180K | 12.1% | 9.27K | 8.14K |
| Total | +0.00 | -$146.70K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.13K shares
Shares
−1.13K
Strike price
29.60
Held after
4.50K
Exercisable
—
12/8/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.13K shares | 12/8/2020 | M · Option Exercise | −1.13K | 29.60 | — | 4.50K |